Chinese brain-computer interface company BrainCo is developing a wearable device that it says can suppress appetite by stimulating the brain, according to Bloomberg. The company is positioning the product as a potential non-drug alternative to GLP-1 weight-loss medications. The report did not disclose a launch timeline, technical specifications, or clinical data. Bloomberg was cited as the source of the claim. The development points to BrainCo’s effort to apply brain-computer interface technology to appetite control through a wearable form factor rather than a pharmaceutical treatment.
Chinese brain-computer interface company BrainCo is developing a wearable device that it says can suppress appetite by stimulating the brain, according to Bloomberg.
The company is aiming for the product to serve as a potential non-drug alternative to GLP-1 weight-loss drugs.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.